Christopher R. Fenimore - Dec 16, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/**Christopher R. Fenimore
Stock symbol
REGN
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/20/2022, 03:06 PM
Previous filing
Dec 13, 2022
Next filing
Feb 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +1.93K +11.56% $0.00 18.6K Dec 16, 2022 Direct F1
holding REGN Common Stock 1.78K Dec 16, 2022 2021 GRAT
holding REGN Common Stock 5K Dec 16, 2022 2022 GRAT
holding REGN Common Stock 1.48K Dec 16, 2022 By 401(k) Plan
holding REGN Common Stock 1.9K Dec 16, 2022 By Trust F2
holding REGN Common Stock 461 Dec 16, 2022 by Trust for Daugh
holding REGN Common Stock 460 Dec 16, 2022 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +7.11K $0.00 7.11K Dec 16, 2022 Common Stock 7.11K $726.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.
F2 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
F3 The stock option award vests in four equal annual installments, commencing one year after the date of grant.